Literature DB >> 18328890

Natural history of asthma: persistence versus progression-does the beginning predict the end?

Reynold A Panettieri1, Ronina Covar, Evalyn Grant, Elizabeth V Hillyer, Leonard Bacharier.   

Abstract

Environmental exposures during the early years and airway obstruction that develops during this time, in conjunction with genetic susceptibility, are important factors in the development of persistent asthma in childhood. Established risk factors for childhood asthma include frequent wheezing during the first 3 years, a parental history of asthma, a history of eczema, allergic rhinitis, wheezing apart from colds, and peripheral blood eosinophilia, as well as allergic sensitization to aeroallergens and certain foods. Risk factors for the development of asthma in adulthood remain ill defined. Moreover, reasons for variability in the clinical course of asthma--persistence in some individuals and progression in others--remain an enigma. The distinction between disease persistence and disease progression suggests that these are different entities or phenotypes. There is currently no consensus on whether disease progression requires either airway inflammation or airway remodeling or the combination of the two. For patients with irreversible airway obstruction, inflammation might, in part, be necessary but perhaps not entirely sufficient to induce the irreversible component, some of which could be attributed to alterations in the structure of the bronchial wall. Intervening with intermittent or daily inhaled corticosteroids in high-risk infants and children does not prevent disease progression or impaired lung growth. These findings, however, might not apply to adults, and further study in adults is needed to determine the effect of inhaled corticosteroid therapy on disease progression.

Entities:  

Mesh:

Year:  2008        PMID: 18328890     DOI: 10.1016/j.jaci.2008.01.006

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  22 in total

1.  Inhaled house dust programs pulmonary dendritic cells to promote type 2 T-cell responses by an indirect mechanism.

Authors:  Timothy P Moran; Keiko Nakano; Gregory S Whitehead; Seddon Y Thomas; Donald N Cook; Hideki Nakano
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-09-18       Impact factor: 5.464

Review 2.  Cross-roads in the lung: immune cells and tissue interactions as determinants of allergic asthma.

Authors:  Lakshmi Ramakrishna; Victor Christoff de Vries; Maria Alicia Curotto de Lafaille
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

3.  Rural health disparities in asthma care and outcomes.

Authors:  Robert S Valet; Tamara T Perry; Tina V Hartert
Journal:  J Allergy Clin Immunol       Date:  2009-02-23       Impact factor: 10.793

4.  Maternal stress and perinatal programming in the expression of atopy.

Authors:  Rosalind J Wright; Michelle Bosquet Enlow
Journal:  Expert Rev Clin Immunol       Date:  2008-09-01       Impact factor: 4.473

Review 5.  A new look at the pathogenesis of asthma.

Authors:  Stephen T Holgate; Hasan S Arshad; Graham C Roberts; Peter H Howarth; Philipp Thurner; Donna E Davies
Journal:  Clin Sci (Lond)       Date:  2009-12-23       Impact factor: 6.124

6.  In vitro and in vivo pharmacological profile of PL-3994, a novel cyclic peptide (Hept-cyclo(Cys-His-Phe-d-Ala-Gly-Arg-d-Nle-Asp-Arg-Ile-Ser-Cys)-Tyr-[Arg mimetic]-NH(2)) natriuretic peptide receptor-A agonist that is resistant to neutral endopeptidase and acts as a bronchodilator.

Authors:  Jeffrey D Edelson; Marie Makhlina; Kevin R Silvester; Shailesh S Vengurlekar; Xiaomei Chen; Jie Zhang; Cynthia J Koziol-White; Philip R Cooper; Trevor J Hallam; Douglas W P Hay; Reynold A Panettieri
Journal:  Pulm Pharmacol Ther       Date:  2012-11-12       Impact factor: 3.410

Review 7.  An imbalance in C/EBPs and increased mitochondrial activity in asthmatic airway smooth muscle cells: novel targets in asthma therapy?

Authors:  Michael Roth; Judith L Black
Journal:  Br J Pharmacol       Date:  2009-04-03       Impact factor: 8.739

Review 8.  The irreversible component of persistent asthma.

Authors:  Rodolfo M Pascual; Stephen P Peters
Journal:  J Allergy Clin Immunol       Date:  2009-11       Impact factor: 10.793

9.  Functional Effects of WNT1-Inducible Signaling Pathway Protein-1 on Bronchial Smooth Muscle Cell Migration and Proliferation in OVA-Induced Airway Remodeling.

Authors:  Mingjin Yang; Yuejun Du; Zhibo Xu; Youfan Jiang
Journal:  Inflammation       Date:  2016-02       Impact factor: 4.092

10.  Risk of asthmatic episodes in children exposed to sulfur dioxide stack emissions from a refinery point source in Montreal, Canada.

Authors:  Audrey Smargiassi; Tom Kosatsky; John Hicks; Céline Plante; Ben Armstrong; Paul J Villeneuve; Sophie Goudreau
Journal:  Environ Health Perspect       Date:  2008-10-21       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.